Cosmetic iris implants can cause serious ocular complaints

Article

The use of cosmetic iris implants could result in ocular complaints such as uveitis, glaucoma, corneal oedema and decreased visual acuity.

The use of cosmetic iris implants could result in ocular complaints such as uveitis, glaucoma, corneal oedema and decreased visual acuity, reveals a study in the Journal of Cataract and Refractive Surgery.

Dr David Ritterband et al., The New York Eye and Ear Infirmary, Valhalla, New York, USA, completed a case series on 14 eyes of 7 patients with cosmetic iris implants. The group gathered information including patient demographics, visual acuity, intraocular pressure (IOP), endothelial cell count and slit-lamp examination findings at presentation.

Decreased visual acuity was found in nine eyes, elevated IOP in 7 eyes, corneal oedema in 5 eyes and anterior uveitis in 5 eyes. Intraoperative complication discovered in one eye as suprachoroidal hemorrhage during explantation.

The investigation found a number of postoperative complications including corneal oedema in 8 eyes, cataract in 9 eyes and elevated IOP/glaucoma in 7 eyes. Additional surgeries performed were Descemet-stripping automated endothelial keratoplasty in 5 eyes, cataract extraction and IOL lens placement in 7 eyes, trabeculectomy in 3 eyes, glaucoma drainage implant placement in 3 eyes and penetrating keratoplasty in 1 eye.

Explanation helped to alleviate symptoms but additional surgery and medication was required to lower IOP. Corneal decompensation was also needed for the majority of patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.